CD46 and cancer: Nevertheless, the majority of the tumor cell lines we studied showed increase in sensitivity to oncolytic MV infection when overexpressing CD46, thereby showing that lung and colorectal cancers, which are highly resistant to conventional treatments, are suitable targets for MV cancer virotherapy.